Broker’s call: Divi’s Lab (Sell)
Target: ₹3,890 CMP: ₹5,893.80 Divi’s Laboratories -Q2FY24 revenue came in better than our estimates but EBITDA margin was lower. As
Continue reading
Tag: Divi's Laboratories
Valuations may offset Q4 show, growth outlook for Divi’s Laboratories
3 min read Last Updated : May 27 2024 | 9:16 PM IST Divi’s Laboratories, the country’s second-largest pharma
Continue reading